In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a cefodizime Drug Master File in Korea (cefodizime KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of cefodizime. The MFDS reviews the cefodizime KDMF as part of the drug registration process and uses the information provided in the cefodizime KDMF to evaluate the safety and efficacy of the drug.
After submitting a cefodizime KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their cefodizime API can apply through the Korea Drug Master File (KDMF).
click here to find a list of cefodizime suppliers with KDMF on PharmaCompass.